Selected research
Industry Growth & Trends
Global Pharma Grade Polyvinylpyrrolidone Industry Growth and Trends Forecast to 2032
Market perspective
The global Pharma Grade Polyvinylpyrrolidone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Pharma Grade Polyvinylpyrrolidone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Pharma Grade Polyvinylpyrrolidone is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pharma Grade Polyvinylpyrrolidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Pharma Grade Polyvinylpyrrolidone include BASF, Ashland, Boai NKY Medical Holdings, JH Nanhang Life Sciences, Chongqing Star-Tech Specialty Products, Huangshan Bonsun Pharmaceuticals, Shanghai Yuking Water Soluble Material Tech, Shanghai Qifuqing Material Technology and Jiaozuo Zhongwei Special Products Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Pharma Grade Polyvinylpyrrolidone market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Pharma Grade Polyvinylpyrrolidone market size, estimates, and forecasts are presented in terms of sales volume (t) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pharma Grade Polyvinylpyrrolidone market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pharma Grade Polyvinylpyrrolidone.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Pharma Grade Polyvinylpyrrolidone market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Pharma Grade Polyvinylpyrrolidone Market by Company
BASF
Ashland
Boai NKY Medical Holdings
JH Nanhang Life Sciences
Chongqing Star-Tech Specialty Products
Huangshan Bonsun Pharmaceuticals
Shanghai Yuking Water Soluble Material Tech
Shanghai Qifuqing Material Technology
Jiaozuo Zhongwei Special Products Pharmaceutical
CNSIG Anhui Hongsifang Fertilizer
Pharma Grade Polyvinylpyrrolidone Segment by Type
K17
K25
K30
K90
Other
Pharma Grade Polyvinylpyrrolidone Segment by Application
Oral Preparations
Injectable Preparations
Topical Preparations
Others
Pharma Grade Polyvinylpyrrolidone Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma Grade Polyvinylpyrrolidone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharma Grade Polyvinylpyrrolidone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma Grade Polyvinylpyrrolidone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharma Grade Polyvinylpyrrolidone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Pharma Grade Polyvinylpyrrolidone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- K17
- K25
- K30
- K90
- Other
Applications
- Oral Preparations
- Injectable Preparations
- Topical Preparations
- Others
Companies covered
- BASF
- Ashland
- Boai NKY Medical Holdings
- JH Nanhang Life Sciences
- Chongqing Star-Tech Specialty Products
- Huangshan Bonsun Pharmaceuticals
- Shanghai Yuking Water Soluble Material Tech
- Shanghai Qifuqing Material Technology
- Jiaozuo Zhongwei Special Products Pharmaceutical
- CNSIG Anhui Hongsifang Fertilizer
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Pharma Grade Polyvinylpyrrolidone Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Pharma Grade Polyvinylpyrrolidone Sales Estimates and Forecasts (2021-2032)
- 1.3 Pharma Grade Polyvinylpyrrolidone Market by Type
- 1.3.1 K17
- 1.3.2 K25
- 1.3.3 K30
- 1.3.4 K90
- 1.3.5 Other
- 1.4 Global Pharma Grade Polyvinylpyrrolidone Market Size by Type
- 1.4.1 Global Pharma Grade Polyvinylpyrrolidone Market Size Overview by Type (2021-2032)
- 1.4.2 Global Pharma Grade Polyvinylpyrrolidone Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Pharma Grade Polyvinylpyrrolidone Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Pharma Grade Polyvinylpyrrolidone Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Pharma Grade Polyvinylpyrrolidone Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Pharma Grade Polyvinylpyrrolidone Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Pharma Grade Polyvinylpyrrolidone Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Pharma Grade Polyvinylpyrrolidone Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Pharma Grade Polyvinylpyrrolidone Industry Trends
- 2.2 Pharma Grade Polyvinylpyrrolidone Industry Drivers
- 2.3 Pharma Grade Polyvinylpyrrolidone Industry Opportunities and Challenges
- 2.4 Pharma Grade Polyvinylpyrrolidone Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Pharma Grade Polyvinylpyrrolidone Revenue (2021-2026)
- 3.2 Global Top Players by Pharma Grade Polyvinylpyrrolidone Sales (2021-2026)
- 3.3 Global Top Players by Pharma Grade Polyvinylpyrrolidone Price (2021-2026)
- 3.4 Global Pharma Grade Polyvinylpyrrolidone Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Pharma Grade Polyvinylpyrrolidone Major Company Production Sites & Headquarters
- 3.6 Global Pharma Grade Polyvinylpyrrolidone Company, Product Type & Application
- 3.7 Global Pharma Grade Polyvinylpyrrolidone Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Pharma Grade Polyvinylpyrrolidone Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Pharma Grade Polyvinylpyrrolidone Players Market Share by Revenue in 2025
- 3.8.3 2025 Pharma Grade Polyvinylpyrrolidone Tier 1, Tier 2, and Tier 3
4 Pharma Grade Polyvinylpyrrolidone Regional Status and Outlook
- 4.1 Global Pharma Grade Polyvinylpyrrolidone Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Pharma Grade Polyvinylpyrrolidone Historic Market Size by Region
- 4.2.1 Global Pharma Grade Polyvinylpyrrolidone Sales in Volume by Region (2021-2026)
- 4.2.2 Global Pharma Grade Polyvinylpyrrolidone Sales in Value by Region (2021-2026)
- 4.2.3 Global Pharma Grade Polyvinylpyrrolidone Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Pharma Grade Polyvinylpyrrolidone Forecasted Market Size by Region
- 4.3.1 Global Pharma Grade Polyvinylpyrrolidone Sales in Volume by Region (2027-2032)
- 4.3.2 Global Pharma Grade Polyvinylpyrrolidone Sales in Value by Region (2027-2032)
- 4.3.3 Global Pharma Grade Polyvinylpyrrolidone Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pharma Grade Polyvinylpyrrolidone by Application
- 5.1 Pharma Grade Polyvinylpyrrolidone Market by Application
- 5.1.1 Oral Preparations
- 5.1.2 Injectable Preparations
- 5.1.3 Topical Preparations
- 5.1.4 Others
- 5.2 Global Pharma Grade Polyvinylpyrrolidone Market Size by Application
- 5.2.1 Global Pharma Grade Polyvinylpyrrolidone Market Size Overview by Application (2021-2032)
- 5.2.2 Global Pharma Grade Polyvinylpyrrolidone Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Pharma Grade Polyvinylpyrrolidone Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Pharma Grade Polyvinylpyrrolidone Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Pharma Grade Polyvinylpyrrolidone Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Pharma Grade Polyvinylpyrrolidone Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Pharma Grade Polyvinylpyrrolidone Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Pharma Grade Polyvinylpyrrolidone Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 BASF
- 6.1.1 BASF Company Information
- 6.1.2 BASF Business Overview
- 6.1.3 BASF Pharma Grade Polyvinylpyrrolidone Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 BASF Pharma Grade Polyvinylpyrrolidone Product Portfolio
- 6.1.5 BASF Recent Developments
- 6.2 Ashland
- 6.2.1 Ashland Company Information
- 6.2.2 Ashland Business Overview
- 6.2.3 Ashland Pharma Grade Polyvinylpyrrolidone Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Ashland Pharma Grade Polyvinylpyrrolidone Product Portfolio
- 6.2.5 Ashland Recent Developments
- 6.3 Boai NKY Medical Holdings
- 6.3.1 Boai NKY Medical Holdings Company Information
- 6.3.2 Boai NKY Medical Holdings Business Overview
- 6.3.3 Boai NKY Medical Holdings Pharma Grade Polyvinylpyrrolidone Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Boai NKY Medical Holdings Pharma Grade Polyvinylpyrrolidone Product Portfolio
- 6.3.5 Boai NKY Medical Holdings Recent Developments
- 6.4 JH Nanhang Life Sciences
- 6.4.1 JH Nanhang Life Sciences Company Information
- 6.4.2 JH Nanhang Life Sciences Business Overview
- 6.4.3 JH Nanhang Life Sciences Pharma Grade Polyvinylpyrrolidone Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 JH Nanhang Life Sciences Pharma Grade Polyvinylpyrrolidone Product Portfolio
- 6.4.5 JH Nanhang Life Sciences Recent Developments
- 6.5 Chongqing Star-Tech Specialty Products
- 6.5.1 Chongqing Star-Tech Specialty Products Company Information
- 6.5.2 Chongqing Star-Tech Specialty Products Business Overview
- 6.5.3 Chongqing Star-Tech Specialty Products Pharma Grade Polyvinylpyrrolidone Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Chongqing Star-Tech Specialty Products Pharma Grade Polyvinylpyrrolidone Product Portfolio
- 6.5.5 Chongqing Star-Tech Specialty Products Recent Developments
- 6.6 Huangshan Bonsun Pharmaceuticals
- 6.6.1 Huangshan Bonsun Pharmaceuticals Company Information
- 6.6.2 Huangshan Bonsun Pharmaceuticals Business Overview
- 6.6.3 Huangshan Bonsun Pharmaceuticals Pharma Grade Polyvinylpyrrolidone Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Huangshan Bonsun Pharmaceuticals Pharma Grade Polyvinylpyrrolidone Product Portfolio
- 6.6.5 Huangshan Bonsun Pharmaceuticals Recent Developments
- 6.7 Shanghai Yuking Water Soluble Material Tech
- 6.7.1 Shanghai Yuking Water Soluble Material Tech Company Information
- 6.7.2 Shanghai Yuking Water Soluble Material Tech Business Overview
- 6.7.3 Shanghai Yuking Water Soluble Material Tech Pharma Grade Polyvinylpyrrolidone Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Shanghai Yuking Water Soluble Material Tech Pharma Grade Polyvinylpyrrolidone Product Portfolio
- 6.7.5 Shanghai Yuking Water Soluble Material Tech Recent Developments
- 6.8 Shanghai Qifuqing Material Technology
- 6.8.1 Shanghai Qifuqing Material Technology Company Information
- 6.8.2 Shanghai Qifuqing Material Technology Business Overview
- 6.8.3 Shanghai Qifuqing Material Technology Pharma Grade Polyvinylpyrrolidone Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Shanghai Qifuqing Material Technology Pharma Grade Polyvinylpyrrolidone Product Portfolio
- 6.8.5 Shanghai Qifuqing Material Technology Recent Developments
- 6.9 Jiaozuo Zhongwei Special Products Pharmaceutical
- 6.9.1 Jiaozuo Zhongwei Special Products Pharmaceutical Company Information
- 6.9.2 Jiaozuo Zhongwei Special Products Pharmaceutical Business Overview
- 6.9.3 Jiaozuo Zhongwei Special Products Pharmaceutical Pharma Grade Polyvinylpyrrolidone Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Jiaozuo Zhongwei Special Products Pharmaceutical Pharma Grade Polyvinylpyrrolidone Product Portfolio
- 6.9.5 Jiaozuo Zhongwei Special Products Pharmaceutical Recent Developments
- 6.10 CNSIG Anhui Hongsifang Fertilizer
- 6.10.1 CNSIG Anhui Hongsifang Fertilizer Company Information
- 6.10.2 CNSIG Anhui Hongsifang Fertilizer Business Overview
- 6.10.3 CNSIG Anhui Hongsifang Fertilizer Pharma Grade Polyvinylpyrrolidone Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 CNSIG Anhui Hongsifang Fertilizer Pharma Grade Polyvinylpyrrolidone Product Portfolio
- 6.10.5 CNSIG Anhui Hongsifang Fertilizer Recent Developments
7 North America by Country
- 7.1 North America Pharma Grade Polyvinylpyrrolidone Sales by Country
- 7.1.1 North America Pharma Grade Polyvinylpyrrolidone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Pharma Grade Polyvinylpyrrolidone Sales by Country (2021-2026)
- 7.1.3 North America Pharma Grade Polyvinylpyrrolidone Sales Forecast by Country (2027-2032)
- 7.2 North America Pharma Grade Polyvinylpyrrolidone Market Size by Country
- 7.2.1 North America Pharma Grade Polyvinylpyrrolidone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Pharma Grade Polyvinylpyrrolidone Market Size by Country (2021-2026)
- 7.2.3 North America Pharma Grade Polyvinylpyrrolidone Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Pharma Grade Polyvinylpyrrolidone Sales by Country
- 8.1.1 Europe Pharma Grade Polyvinylpyrrolidone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Pharma Grade Polyvinylpyrrolidone Sales by Country (2021-2026)
- 8.1.3 Europe Pharma Grade Polyvinylpyrrolidone Sales Forecast by Country (2027-2032)
- 8.2 Europe Pharma Grade Polyvinylpyrrolidone Market Size by Country
- 8.2.1 Europe Pharma Grade Polyvinylpyrrolidone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Pharma Grade Polyvinylpyrrolidone Market Size by Country (2021-2026)
- 8.2.3 Europe Pharma Grade Polyvinylpyrrolidone Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Pharma Grade Polyvinylpyrrolidone Sales by Country
- 9.1.1 Asia-Pacific Pharma Grade Polyvinylpyrrolidone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Pharma Grade Polyvinylpyrrolidone Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Pharma Grade Polyvinylpyrrolidone Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Pharma Grade Polyvinylpyrrolidone Market Size by Country
- 9.2.1 Asia-Pacific Pharma Grade Polyvinylpyrrolidone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Pharma Grade Polyvinylpyrrolidone Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Pharma Grade Polyvinylpyrrolidone Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Pharma Grade Polyvinylpyrrolidone Sales by Country
- 10.1.1 South America Pharma Grade Polyvinylpyrrolidone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Pharma Grade Polyvinylpyrrolidone Sales by Country (2021-2026)
- 10.1.3 South America Pharma Grade Polyvinylpyrrolidone Sales Forecast by Country (2027-2032)
- 10.2 South America Pharma Grade Polyvinylpyrrolidone Market Size by Country
- 10.2.1 South America Pharma Grade Polyvinylpyrrolidone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Pharma Grade Polyvinylpyrrolidone Market Size by Country (2021-2026)
- 10.2.3 South America Pharma Grade Polyvinylpyrrolidone Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Pharma Grade Polyvinylpyrrolidone Sales by Country
- 11.1.1 Middle East and Africa Pharma Grade Polyvinylpyrrolidone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Pharma Grade Polyvinylpyrrolidone Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Pharma Grade Polyvinylpyrrolidone Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Pharma Grade Polyvinylpyrrolidone Market Size by Country
- 11.2.1 Middle East and Africa Pharma Grade Polyvinylpyrrolidone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Pharma Grade Polyvinylpyrrolidone Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Pharma Grade Polyvinylpyrrolidone Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Pharma Grade Polyvinylpyrrolidone Value Chain Analysis
- 12.1.1 Pharma Grade Polyvinylpyrrolidone Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Pharma Grade Polyvinylpyrrolidone Production Mode & Process
- 12.2 Pharma Grade Polyvinylpyrrolidone Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Pharma Grade Polyvinylpyrrolidone Distributors
- 12.2.3 Pharma Grade Polyvinylpyrrolidone Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst